CSL Ltd Annual Report 2020

5.3.4 Executive KMP 2021 equity vesting opportunity In 2021, our final legacy LTI awards will be tested which will result in one further year of complexity in the reporting of awards that either vest or lapse across multiple award securities and terms and conditions, including performance measures. In regard to the awards granted in 2017 (grant date of 1 October 2016), the value of any vesting is expected to be high – as has been the case over the past two years. This outcome reflects the exceptionally strong CSL share price over the performance period. The high vesting value is also in line with the shareholder returns over the same period. The following tables set out a preview of the awards that will be tested in 2021 for Executive KMP with Table 8 providing the specific grant details for each Executive KMP. The face value in Table 7 is provided in Australian Dollars. Table 7: LTI awards to be tested in 2021 Grant Date Security Performance Measure Exercise Price A$ Face Value of a CSL Share at Date of Grant A$ 1 October 2016 Option Individual Performance 107.25 107.00 1 October 2016 Right Relative Total Shareholder Return (rTSR) – 107.00 1 October 2016 Right Earnings per Share growth (EPSg) – 107.00 1 October 2017 Performance Share Unit ROIC – 133.96 1 September 2018 Performance Share Unit ROIC – 227.31 1 September 2019 Performance Share Unit ROIC – 240.87 Table 8: Executive KMP LTI opportunity to be tested in 2021 Executive Number of Options Number of Performance Rights Number of Performance Share Units P Perreault 163,514 51,727 33,452 A Cuthbertson – 11,389 6,491 D Lamont – 11,683 5,630 P McKenzie – – 10,084 CSL Limited Annual Report 2020 81